NCT00005871View on ClinicalTrials.gov

Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer

PHASE3UnknownINTERVENTIONAL
Timeline

Start Date

November 30, 1998

Conditions
Pancreatic Cancer
Interventions
DRUG

fluorouracil

DRUG

rubitecan

Trial Locations (1)

94583

SuperGen, Incorporated, San Ramon

Sponsors
All Listed Sponsors
lead

Astex Pharmaceuticals, Inc.

INDUSTRY